Use of anti-tissue factor antibodies for treating thromboses
US7968094B2 · kind B2 · utility
20Cited by
42References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2008 |
| Grant date | Jun 28, 2011 |
| Priority date | — |
| Expiry date | Jul 31, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for preventing or treating thrombosis in a mammal such as a primate and particularly a human patient. A preferred method includes administering to the mammal a therapeutically effective amount of at least one humanized antibody, chimeric antibody, or fragment thereof that binds specifically to human tissue factor (TF). Additional methods and kits are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.